What is the impact of preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score?
The study by DeFilippis et al. (2017) found that the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease (AHA-ACC-ASCVD) risk score was overestimated due to the inclusion of preventive therapies. The study concluded that the inclusion of preventive therapies in the AHA-ACC-ASCVD risk score led to an overestimation of risk, highlighting the need for improved risk score models for more accurate risk prediction.